Kidtrayze (Zinc Chloride, Potassium Iodide, Sodium Selenite, Copper Chloride Dihydrate, Manganese Chloride Tetr)

Zinc chloride, together with the other trace elements in Kidtrayze, provides essential cofactors for enzymatic reactions. Zinc specifically supports DNA synthesis, protein production, immune function and wound healing. By delivering zinc directly into the bloodstream, the formulation bypasses gastrointestinal barriers and quickly restores cellular zinc levels needed for metabolic processes.

The appropriate dose of Kidtrayze is determined by the prescribing clinician based on the patient’s age, weight, clinical condition and laboratory results. Dosing is individualized to achieve target serum trace‑element concentrations and is adjusted according to ongoing monitoring. No fixed regimen is provided here.

Safety data for Kidtrayze in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother or infant outweighs any possible risk. The prescribing physician must evaluate the individual situation and consider alternative therapies if appropriate.

To order Kidtrayze, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including cold‑chain handling if needed) and assists with import documentation.

Kidtrayze offers a balanced combination of five essential trace elements in a single intravenous formulation, simplifying preparation compared with multi‑component kits that require separate mixing. Its EU‑origin manufacturing follows GMP standards, providing consistent quality. Alternative products may contain a different spectrum of elements or varying concentrations, so clinicians choose based on the specific trace‑element profile required for the patient.

Kidtrayze must be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Before administration, allow the product to reach room temperature if required by the hospital protocol and inspect for any particulate matter or discoloration.

Kidtrayze is administered intravenously, typically as an infusion added to a compatible carrier solution. The infusion rate and total volume are set by the prescribing clinician and should be delivered under aseptic conditions using an infusion pump or controlled drip to ensure accurate dosing and minimize infusion‑related reactions.

The most serious adverse events associated with Kidtrayze include anaphylactic or severe hypersensitivity reactions, marked electrolyte disturbances such as hyper‑copper or hyper‑zinc states, and acute renal or hepatic impairment. Prompt recognition of symptoms like difficulty breathing, sudden drop in blood pressure, or abnormal laboratory values is essential for immediate medical intervention.

Kidtrayze should be avoided in patients with known hypersensitivity to any of its components, in those with severe renal or hepatic failure where trace‑element clearance is compromised, and in individuals receiving conflicting high‑dose trace‑element supplements without medical supervision. Use in these populations requires careful risk‑benefit assessment by a qualified healthcare professional.